Pathobiology, classification, and diagnosis of myelodysplastic syndrome

This publication has 57 references indexed in Scilit:

• Additional Prognostic Value of Bone Marrow Histology in Patients Subclassified According to the International Prognostic Scoring System for Myelodysplastic Syndromes
  Journal of Clinical Oncology, 2003
• Activity of the caspase-3/CPP32 enzyme is increased in “early stage” myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro
  Experimental Hematology, 2000
• Correlation of tumor necrosis factor α (TNFα) with high Caspase 3-like activity in myelodysplastic syndromes
  Published by Elsevier ,1999
• P15^INK4bGene Methylation and Myelodysplastic Syndromes
  Leukemia & Lymphoma, 1999
• Telomere length in myelodysplastic syndromes
  American Journal of Hematology, 1997
• Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes
  Leukemia, 1997
• Oxidative DNA damage in CD34⁺ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor‐α concentration
  British Journal of Haematology, 1997
• CD34 immunohistochemistry of bone marrow biopsies: Prognostic significance in primary myelodysplastic syndromes
  American Journal of Hematology, 1994
• Benzene and Leukemia
  New England Journal of Medicine, 1987
• The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations
  British Journal of Haematology, 1985